A Trial to Compare the Outcome of Localised Varicosity Compression for 24 Hours and 5 Days After Foam Sclerotherapy to Truncal Varices
A Randomised Controlled Trial to Compare the Outcome of Localised Varicosity Compression for 24 Hours and 5 Days After Foam Sclerotherapy to Truncal Varices
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gloucestershire
-
Gloucester, Gloucestershire, United Kingdom, GL1 3NN
- Gloucestershire Royal Hospital NHS Trust
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Proven truncal venous incompetence (of >1 second duration) on venous duplex scanning. (Great saphenous vein (GSV), small saphenous vein (SSV), anterior accessory thigh vein (AATV) or other major tributary).
- Agreed preference for foam sclerotherapy treatment.
- Signed consent form agreeing to be part of the trial.
Exclusion Criteria:
- Total deep venous reflux.
- Known allergy to liquid sclerosant.
- Pregnancy or breast feeding.
- Arterial disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: 24 hours compression bandaging
|
Cotton wool padding will then be placed over the treated vein and secured in place by crepe bandaging.
An above-knee TED stocking will be applied on top of this.
|
|
Active Comparator: 5 days compression bandaging
|
Cotton wool padding will then be placed over the treated vein and secured in place by crepe bandaging.
An above-knee TED stocking will be applied on top of this.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Aberdeen Varicose Vein Score from time of treatment to 2 and 6 weeks after treatment
Time Frame: 2 and 6 weeks
|
2 and 6 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Burford pain score from time of treatment to 2 and 6 weeks after treatment
Time Frame: 2 and 6 weeks
|
2 and 6 weeks
|
|
Change in SF-36 score from time of treatment to 6 weeks after treatment.
Time Frame: 6 weeks
|
6 weeks
|
|
Target vein occlusion rate on duplex imaging at 6 weeks
Time Frame: 6 weeks
|
6 weeks
|
|
Number and type of complications seen
Time Frame: 6 weeks
|
6 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jonothan J Earnshaw, FRCS, MD, Gloucestershire Royal Hospital NHS Trust
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 06/Q2005/128
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.